Hautala Timo, Syrjälä Hannu, Lehtinen Ville, Kauma Heikki, Kauppila Jaana, Kujala Pekka, Pietarinen Ilmo, Ylipalosaari Pekka, Koskela Markku
Department of Internal Medicine, Oulu University Hospital, P.O. Box 5000, FIN-90014 Oulu, Finland.
Int J Antimicrob Agents. 2005 Apr;25(4):329-33. doi: 10.1016/j.ijantimicag.2004.11.015.
Early antimicrobial treatment has a great influence on the outcome of patients with blood stream infections (BSI). The study was designed to see if the simple practice of patient categorization (community acquired, nosocomial or infection in haematological unit) combined with Gram stain data could be used to guide empirical treatment of BSI in 1901 consecutive positive blood culture findings. There were considerable differences in the occurrence of common pathogens and their antimicrobial susceptibilities between patient categories especially for Gram-positive cocci. For example, second generation cephalosporins covered more than 70% cocci in clusters and over 80% of cocci in chains in community acquired infections whereas in hospital acquired infections the corresponding figures were only 47 and 44%. We conclude that Gram stain results of positive blood cultures along with the knowledge of where the infection was acquired, would allow early accurate targeting of antimicrobial therapy for BSI.
早期抗菌治疗对血流感染(BSI)患者的预后有很大影响。本研究旨在探讨患者分类(社区获得性、医院获得性或血液科感染)这一简单做法与革兰氏染色数据相结合,是否可用于指导对1901例连续血培养阳性结果的BSI患者进行经验性治疗。不同类别患者中常见病原体的发生率及其抗菌药物敏感性存在显著差异,尤其是革兰氏阳性球菌。例如,在社区获得性感染中,第二代头孢菌素对簇状球菌的覆盖率超过70%,对链状球菌的覆盖率超过80%,而在医院获得性感染中,相应的数字仅为47%和44%。我们得出结论,血培养阳性的革兰氏染色结果以及感染获得部位的信息,将有助于早期准确地针对BSI进行抗菌治疗。